Amplify Energy Announces Successful Borrowing Base Redetermination
Globenewswire· 2025-05-29 20:30
HOUSTON, May 29, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that it completed its regularly scheduled semi-annual borrowing base redetermination. The redetermination affirmed the borrowing base at $145 million. The next regularly scheduled borrowing base redetermination is expected to occur in the fourth quarter of 2025. Martyn Willsher, Amplify’s President and Chief Executive Officer commented, “I would like to express my appreciation to our synd ...
Bowen Acquisition Corp Receives NASDAQ Notification of Non-Compliance with Listing Rules
Globenewswire· 2025-05-29 20:30
New York, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ: BOWN) (“BOWN”), a special purpose acquisition company, announced that on May 28, 2025, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“NASDAQ”) advising the Company that the Company does not comply with NASDAQ’s Listing Rule 5250(c)(1) for continued listing because NASDAQ has not received the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 (the “Form ...
New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes
Globenewswire· 2025-05-29 20:30
Study results show that DecisionDx-Melanoma was associated with a 32% reduction in mortality risk compared to untested patientsFRIENDSWOOD, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present novel research aimed at enhancing the clinical management of patients with cutaneous melanoma (CM) and uveal melanoma (UM) at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, being ...
Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
Globenewswire· 2025-05-29 20:23
ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (the “Company” or “Femasys”), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. In addition, Femasys expects to grant the underwriters a 30-day option to purchase up to an additional 15% ...
Palomar Holdings, Inc. Announces Successful Completion of June 1 Reinsurance Placement
Globenewswire· 2025-05-29 20:15
~ Full-Year 2025 Adjusted Net Income Guidance Increased to $195 Million to $205 Million ~ LA JOLLA, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ: PLMR) (“Palomar” or the “Company”) today announced the successful completion of certain reinsurance programs incepting June 1, 2025, and increased the Company’s full year 2025 adjusted net income guidance. The Company has procured approximately $455 million of incremental limit to support the growth of its Earthquake franchise. Palomar’s ...
Costco Wholesale Corporation Reports Third Quarter and Year-To-Date Operating Results for Fiscal 2025
Globenewswire· 2025-05-29 20:15
ISSAQUAH, Wash., May 29, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the third quarter (twelve weeks) and the first 36 weeks of fiscal 2025, ended May 11, 2025. Net sales for the quarter increased 8.0 percent, to $61.96 billion, from $57.39 billion last year. Net sales for the first 36 weeks increased 8.2 percent, to $185.48 billion, from $171.44 billion last year. Comparable sales for the third quarter and first ...
Alumis to Present at the Jefferies Global Healthcare Investor Conference
Globenewswire· 2025-05-29 20:15
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that Martin Babler, President and Chief Executive Officer of Alumis, will present at the Jefferies Global Healthcare Conference on June 4, 2025 at 3:10 p.m. ET. A live webcast will be available on the Alumis website in the "Investors" section under the “Events” page. A replay of the c ...
Medallion Bank Announces Redemption of Its Series F Preferred Stock
Globenewswire· 2025-05-29 20:15
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Medallion Bank (Nasdaq: MBNKP; MBNKO), an FDIC-insured bank providing consumer loans for the purchase of recreational vehicles, boats, and home improvements, along with loan origination services to fintech strategic partners, announced today that on July 1, 2025 (the “Redemption Date”) it will redeem all outstanding shares of its Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series F (the “Series F Preferred Stock”) (Nasdaq: MBNKP) at the redempt ...
Virtu Financial Announces Transfer of Listing of Common Stock to the New York Stock Exchange
Globenewswire· 2025-05-29 20:15
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NASDAQ: VIRT) (“Virtu Financial” or “Virtu”) a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the entire investment cycle to the global markets, today announced plans to transfer the listing of its Class A Common Stock (“Common Stock”) to the New York Stock Exchange (“NYSE”) from the Nasdaq Stock Market LLC. Virtu expects the listing of its Common Stock on Nasdaq ...
Microchip Technology Raises Financial Guidance for Sales and EPS for First Quarter of Fiscal Year 2026
Globenewswire· 2025-05-29 20:15
CHANDLER, Ariz., May 29, 2025 (GLOBE NEWSWIRE) -- Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today updated the range of its prior guidance for net Sales and GAAP and non-GAAP earnings per share for its fiscal first quarter of 2026 ending June 30, 2025. Microchip now expects consolidated net sales for the June quarter to be between $1.045 billion and $1.070 billion. Microchip previously provided guidance on May 8, 2025 of consolidated net ...